Heska Stock Price, News & Analysis (NASDAQ:HSKA)

$80.09 2.49 (3.21 %)
(As of 12/14/2017 04:00 PM ET)
Previous Close$77.60
Today's Range$77.61 - $81.41
52-Week Range$66.51 - $115.00
Volume100,500 shs
Average Volume83,735 shs
Market Capitalization$562.12 million
P/E Ratio40.63
Dividend YieldN/A
Beta0.75

About Heska (NASDAQ:HSKA)

Heska logoHeska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.

Receive HSKA News and Ratings via Email

Sign-up to receive the latest news and ratings for HSKA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Veterinary Medical Equipment & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:HSKA
CUSIPN/A
Phone970-493-7272

Debt

Debt-to-Equity RatioN/A
Current Ratio2.30%
Quick Ratio1.09%

Price-To-Earnings

Trailing P/E Ratio40.63
Forward P/E Ratio39.45
P/E Growth2.07

Sales & Book Value

Annual Sales$130.08 million
Price / Sales4.46
Cash Flow$2.27 per share
Price / Cash35.34
Book Value$12.61 per share
Price / Book6.35

Profitability

Trailing EPS$1.91
Net Income$10.50 million
Net Margins10.67%
Return on Equity15.35%
Return on Assets11.00%

Miscellaneous

Employees327
Outstanding Shares7,240,000

Heska (NASDAQ:HSKA) Frequently Asked Questions

What is Heska's stock symbol?

Heska trades on the NASDAQ under the ticker symbol "HSKA."

How were Heska's earnings last quarter?

Heska Corp (NASDAQ:HSKA) released its quarterly earnings results on Thursday, November, 2nd. The medical research company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.03. The medical research company earned $31.40 million during the quarter, compared to analysts' expectations of $36.10 million. Heska had a net margin of 10.67% and a return on equity of 15.35%. The firm's revenue for the quarter was down 6.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.45 EPS. View Heska's Earnings History.

When will Heska make its next earnings announcement?

Heska is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for Heska.

Where is Heska's stock going? Where will Heska's stock price be in 2017?

6 brokerages have issued 12 month target prices for Heska's shares. Their forecasts range from $93.00 to $129.50. On average, they expect Heska's share price to reach $114.38 in the next twelve months. View Analyst Ratings for Heska.

What are Wall Street analysts saying about Heska stock?

Here are some recent quotes from research analysts about Heska stock:

  • 1. B. Riley analysts commented, "We expect Q3 results to be generally in line. We forecast revenue of $35.8 million and EPS of $0.40 versus consensus of $36.0 million and EPS of $0.41. We model revenue growth at 7.1%, reflecting ongoing momentum in core blood diagnostics within its Core Companion Animal Health offset by Other Vaccines, Pharmaceuticals and Products segment which pulled forward revenue last quarter (but expecting to finish off Q4 strong)." (10/27/2017)
  • 2. According to Zacks Investment Research, "Heska Corporation is focused on the discovery, development and marketing of companion animal health products. In addition to manufacturing certain of companion animal products, the company's primary manufacturing subsidiary, Diamond Animal Health, Inc., also manufactures animal health vaccine products which are marketed and distributed by third parties. In addition to manufacturing veterinary allergy products for marketing and sale by the company, subsidiaries, Center Laboratories, Inc. and CMG-Heska Allergy Products S.A., also manufacture and sell human allergy products. " (10/4/2017)

Who are some of Heska's key competitors?

Who are Heska's key executives?

Heska's management team includes the folowing people:

  • Sharon J. Larson, Independent Chairman of the Board (Age 55)
  • Kevin S. Wilson, President, Chief Executive Officer, Director (Age 44)
  • Catherine Grassman, Principal Financial Officer, Principal Accounting Officer, Vice President, Controller (Age 41)
  • Michael J. McGinley Ph.D., President - Biologicals & Pharmaceuticals (Age 56)
  • Jason A. Napolitano, Chief Operating Officer, Chief Strategist and Secretary (Age 48)
  • Steven M. Eyl, Executive Vice President - Global Sales and Marketing (Age 51)
  • Steven M. Asakowicz, Executive Vice President - Companion Animal Health Sales (Age 51)
  • Rodney A. Lippincott, Executive Vice President - Companion Animal Health Sales (Age 43)
  • Nancy Wisnewski Ph.D., Executive Vice President - Diagnostic Operations and Product Development (Age 54)
  • Scott Humphrey, Director

Who owns Heska stock?

Heska's stock is owned by many different of retail and institutional investors. Top institutional investors include Neuberger Berman Group LLC (8.34%), Riverbridge Partners LLC (2.84%), Dimensional Fund Advisors LP (2.09%), Russell Investments Group Ltd. (2.08%), Wells Fargo & Company MN (1.95%) and Bank of New York Mellon Corp (1.39%). Company insiders that own Heska stock include Carol Wrenn, G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Nancy Wisnewski, Rod Lippincott, Sharon J Larson, Sharon L Riley and Steve Asakowicz. View Institutional Ownership Trends for Heska.

Who sold Heska stock? Who is selling Heska stock?

Heska's stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Riverbridge Partners LLC, Prudential Financial Inc., Cornerstone Capital Management Holdings LLC., GSA Capital Partners LLP, Summit Creek Advisors LLC, Allianz Asset Management GmbH and Grace & White Inc. NY. Company insiders that have sold Heska company stock in the last year include Carol Wrenn, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Nancy Wisnewski, Rod Lippincott and Steve Asakowicz. View Insider Buying and Selling for Heska.

Who bought Heska stock? Who is buying Heska stock?

Heska's stock was purchased by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Wells Fargo & Company MN, Dimensional Fund Advisors LP, Schwab Charles Investment Management Inc., OxFORD Asset Management LLP, Citadel Advisors LLC, Ameriprise Financial Inc. and Trexquant Investment LP. Company insiders that have bought Heska stock in the last two years include Sharon J Larson and Sharon L Riley. View Insider Buying and Selling for Heska.

How do I buy Heska stock?

Shares of Heska can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Heska's stock price today?

One share of Heska stock can currently be purchased for approximately $80.09.

How big of a company is Heska?

Heska has a market capitalization of $562.12 million and generates $130.08 million in revenue each year. The medical research company earns $10.50 million in net income (profit) each year or $1.91 on an earnings per share basis. Heska employs 327 workers across the globe.

How can I contact Heska?

Heska's mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The medical research company can be reached via phone at 970-493-7272 or via email at [email protected]


MarketBeat Community Rating for Heska (HSKA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  163 (Vote Outperform)
Underperform Votes:  186 (Vote Underperform)
Total Votes:  349
MarketBeat's community ratings are surveys of what our community members think about Heska and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Heska (NASDAQ:HSKA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.502.432.332.33
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $105.70$105.70$104.25$94.13
Price Target Upside: 23.01% upside29.28% upside2.55% upside4.60% downside

Heska (NASDAQ:HSKA) Consensus Price Target History

Price Target History for Heska (NASDAQ:HSKA)

Heska (NASDAQ:HSKA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2017Raymond James FinancialReiterated RatingBuyHighView Rating Details
11/3/2017B. RileyLower Price TargetNeutral -> Neutral$96.50 -> $93.00N/AView Rating Details
10/5/2017Canaccord GenuityInitiated CoverageBuy$115.00N/AView Rating Details
8/9/2017BenchmarkReiterated RatingBuy$106.00 -> $120.00HighView Rating Details
8/1/2017AegisBoost Price TargetBuy$114.50 -> $129.50LowView Rating Details
1/26/2017CL KingDowngradeBuy -> NeutralN/AView Rating Details
11/28/2016SidotiDowngradeBuy -> Neutral$71.00N/AView Rating Details
8/4/2016GabelliDowngradeBuy -> HoldN/AView Rating Details
(Data available from 12/14/2015 forward)

Earnings

Heska (NASDAQ:HSKA) Earnings History and Estimates Chart

Earnings by Quarter for Heska (NASDAQ:HSKA)

Heska (NASDAQ HSKA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018        
11/2/2017Q3 2017$0.37$0.40$36.10 million$31.40 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.37$0.44$33.35 million$34.30 millionViewN/AView Earnings Details
5/2/2017Q1 2017$0.24$0.61$33.31 million$30.38 millionViewListenView Earnings Details
2/28/2017Q416$0.37$0.46$34.56 million$39.50 millionViewListenView Earnings Details
11/1/2016Q316$0.26$0.45$31.36 million$33.40 millionViewN/AView Earnings Details
8/3/2016Q216$0.18$0.35$28.47 million$30.00 millionViewN/AView Earnings Details
5/3/2016Q116($0.02)$0.17$23.32 million$27.10 millionViewN/AView Earnings Details
3/3/2016Q415$0.17$0.28$28.31 million$29.80 millionViewN/AView Earnings Details
11/11/2015Q315$0.08$0.20$24.31 million$28.00 millionViewListenView Earnings Details
7/29/2015Q215$0.10$0.17$24.11 million$23.90 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.09$23.97 million$22.90 millionViewN/AView Earnings Details
3/5/2015Q414$0.15$0.12$24.20 million$24.30 millionViewN/AView Earnings Details
10/29/2014Q3 2014($0.01)$0.08$19.39 million$21.81 millionViewN/AView Earnings Details
7/30/2014Q2($0.03)$0.17$19.78 million$22.92 millionViewN/AView Earnings Details
5/8/2014Q1 2014($0.01)$0.03$20.31 million$20.79 millionViewN/AView Earnings Details
3/27/2014$0.04$0.20ViewN/AView Earnings Details
8/7/2013Q2 2013($0.01)($0.38)$19.85 million$18.30 millionViewN/AView Earnings Details
11/13/2012Q312$0.08($0.01)$19.70 million$16.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Heska (NASDAQ:HSKA) Earnings Estimates

2017 EPS Consensus Estimate: $1.67
2018 EPS Consensus Estimate: $2.04
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.20$0.23$0.22
Q2 20172$0.36$0.36$0.36
Q3 20172$0.46$0.51$0.49
Q4 20172$0.61$0.61$0.61
Q1 20181$0.30$0.30$0.30
Q2 20181$0.45$0.45$0.45
Q3 20181$0.56$0.56$0.56
Q4 20181$0.73$0.73$0.73
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Heska (NASDAQ:HSKA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Heska (NASDAQ HSKA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 14.70%
Institutional Ownership Percentage: 81.98%
Insider Trades by Quarter for Heska (NASDAQ:HSKA)
Institutional Ownership by Quarter for Heska (NASDAQ:HSKA)

Heska (NASDAQ HSKA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/29/2017Michael J McginleyInsiderSell7,826$87.14$681,957.64View SEC Filing  
11/27/2017Michael J McginleyInsiderSell1$88.54$88.54View SEC Filing  
8/31/2017Nancy WisnewskiEVPSell825$102.21$84,323.25View SEC Filing  
8/30/2017John McmahonCFOSell2,608$101.17$263,851.36View SEC Filing  
6/1/2017Steve AsakowiczEVPSell382$100.08$38,230.56View SEC Filing  
5/31/2017Michael J McginleyInsiderSell11,189$98.53$1,102,452.17View SEC Filing  
5/31/2017Rod LippincottEVPSell11,227$98.00$1,100,246.00View SEC Filing  
5/24/2017Jason A. NapolitanoCOOSell5,000$100.50$502,500.00View SEC Filing  
5/24/2017Nancy WisnewskiEVPSell250$100.17$25,042.50View SEC Filing  
5/23/2017Carol WrennDirectorSell1,630$96.95$158,028.50View SEC Filing  
5/23/2017John McmahonCFOSell587$97.00$56,939.00View SEC Filing  
5/4/2017Sharon J LarsonDirectorBuy1,000$90.00$90,000.00View SEC Filing  
4/11/2017Jason A. NapolitanoCOOSell1,100$102.98$113,278.00View SEC Filing  
4/10/2017Jason A. NapolitanoCOOSell3,900$102.94$401,466.00View SEC Filing  
3/9/2017John McmahonCFOSell708$97.42$68,973.36View SEC Filing  
3/9/2017Rod LippincottEVPSell5,157$97.87$504,715.59View SEC Filing  
3/6/2017Kevin S WilsonCEOSell8,000$90.00$720,000.00View SEC Filing  
1/10/2017Jason A. NapolitanoCOOSell5,000$74.73$373,650.00View SEC Filing  
11/29/2016G Irwin GordonDirectorSell3,000$66.11$198,330.00View SEC Filing  
11/28/2016John McmahonCFOSell1,999$65.64$131,214.36View SEC Filing  
11/22/2016Rod LippincottEVPSell5,000$64.85$324,250.00View SEC Filing  
9/1/2016Jason A. NapolitanoCFOSell5,000$52.53$262,650.00View SEC Filing  
8/29/2016Kevin S WilsonCEOSell20,000$51.80$1,036,000.00View SEC Filing  
8/24/2016John McmahonVPSell137$51.30$7,028.10View SEC Filing  
8/9/2016Steve AsakowiczEVPSell4,698$52.55$246,879.90View SEC Filing  
8/3/2016Kevin S WilsonCEOSell30,736$47.34$1,455,042.24View SEC Filing  
7/29/2016Kevin S WilsonCEOSell20$43.95$879.00View SEC Filing  
7/20/2016Kevin S WilsonCEOSell3,779$44.02$166,351.58View SEC Filing  
7/18/2016Kevin S WilsonCEOSell5,465$44.31$242,154.15View SEC Filing  
7/8/2016Kevin S WilsonCEOSell10,000$42.37$423,700.00View SEC Filing  
7/7/2016Jason A. NapolitanoCFOSell20,000$41.00$820,000.00View SEC Filing  
7/6/2016Kevin S WilsonCEOSell5,960$40.27$240,009.20View SEC Filing  
7/1/2016Kevin S WilsonCEOSell14,040$38.94$546,717.60View SEC Filing  
6/2/2016Kevin S WilsonCEOSell20,000$36.74$734,800.00View SEC Filing  
5/12/2016Kevin S WilsonCEOSell5,000$38.50$192,500.00View SEC Filing  
5/10/2016Kevin S WilsonCEOSell15,000$36.75$551,250.00View SEC Filing  
5/10/2016Michael J McginleyInsiderSell5,998$36.50$218,927.00View SEC Filing  
5/10/2016Sharon L RileyDirectorSell5,000$36.87$184,350.00View SEC Filing  
5/9/2016Kevin S WilsonCEOSell11,000$35.61$391,710.00View SEC Filing  
5/5/2016Sharon L RileyDirectorSell15,000$35.66$534,900.00View SEC Filing  
5/3/2016Jason A NapolitanoCFOSell5,000$35.75$178,750.00View SEC Filing  
3/8/2016Sharon L RileyDirectorBuy1,000$32.49$32,490.00View SEC Filing  
1/27/2016Jason A NapolitanoCFOSell15,000$37.00$555,000.00View SEC Filing  
12/29/2015Jason A. NapolitanoCFOSell3,700$40.03$148,111.00View SEC Filing  
12/3/2015Kevin S WilsonCEOSell6,000$35.50$213,000.00View SEC Filing  
11/25/2015Michael J. McginleyinsiderSell958$33.62$32,207.96View SEC Filing  
11/24/2015Michael J. McginleyinsiderSell1,427$33.33$47,561.91View SEC Filing  
9/11/2015Jason A NapolitanoCFOSell1,699$33.51$56,933.49View SEC Filing  
8/31/2015Jason A. NapolitanoCFOSell4,998$33.59$167,882.82View SEC Filing  
8/31/2015Robert B. GrieveinsiderSell11,098$33.77$374,779.46View SEC Filing  
8/27/2015Robert B. GrieveinsiderSell3,604$33.79$121,779.16View SEC Filing  
8/17/2015Kevin S WilsonCEOSell2,498$34.90$87,180.20View SEC Filing  
8/17/2015Robert B GrieveInsiderSell8,033$34.91$280,432.03View SEC Filing  
8/14/2015Kevin S WilsonCEOSell2,101$34.90$73,324.90View SEC Filing  
8/14/2015Rod LippincottEVPSell3,898$34.19$133,272.62View SEC Filing  
7/13/2015Robert B GrieveInsiderSell1,000$29.99$29,990.00View SEC Filing  
6/8/2015Kevin S WilsonCEOSell11,810$30.08$355,244.80View SEC Filing  
6/3/2015Robert B GrieveInsiderSell17,000$31.36$533,120.00View SEC Filing  
6/1/2015Jason A NapolitanoCFOSell7,536$32.26$243,111.36View SEC Filing  
5/22/2015Steven M EylEVPSell5,981$30.19$180,566.39View SEC Filing  
4/24/2015Robert B GrieveInsiderSell6,000$29.67$178,020.00View SEC Filing  
4/13/2015Robert B GrieveInsiderSell4,000$26.54$106,160.00View SEC Filing  
3/9/2015Jason A NapolitanoCFOSell5,765$26.02$150,005.30View SEC Filing  
3/9/2015Kevin S WilsonCEOSell10,000$25.38$253,800.00View SEC Filing  
3/9/2015Robert B GrieveInsiderSell2,000$25.26$50,520.00View SEC Filing  
11/30/2014David E SveenDirectorBuy21,428$14.00$299,992.00View SEC Filing  
11/30/2014Kevin S WilsonCEOSell28,928$14.00$404,992.00View SEC Filing  
11/21/2014Robert B GrieveInsiderSell6,500$15.25$99,125.00View SEC Filing  
11/3/2014William A AylesworthDirectorSell5,000$13.67$68,350.00View SEC Filing  
8/4/2014Robert B GrieveDirectorSell12,000$13.57$162,840.00View SEC Filing  
5/14/2014William AylesworthDirectorSell4,200$10.89$45,738.00View SEC Filing  
3/31/2014Carol WrennDirectorBuy1,000$10.50$10,500.00View SEC Filing  
3/31/2014Robert GrieveCEOSell7,000$10.50$73,500.00View SEC Filing  
3/1/2013William A AylesworthDirectorBuy2,000$8.34$16,680.00View SEC Filing  
10/3/2012Master Fund L.P. CmcMajor ShareholderSell11,002$9.54$104,959.08View SEC Filing  
8/28/2012William A AylesworthDirectorBuy2,000$7.95$15,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Heska (NASDAQ HSKA) News Headlines

Source:
DateHeadline
Heska (HSKA) Rating Lowered to Sell at BidaskClubHeska (HSKA) Rating Lowered to Sell at BidaskClub
www.americanbankingnews.com - December 9 at 10:16 AM
Heska (HSKA) Earns "Buy" Rating from Raymond James FinancialHeska (HSKA) Earns "Buy" Rating from Raymond James Financial
www.americanbankingnews.com - December 5 at 1:30 PM
 Analysts Anticipate Heska Corp (HSKA) Will Announce Quarterly Sales of $41.14 Million Analysts Anticipate Heska Corp (HSKA) Will Announce Quarterly Sales of $41.14 Million
www.americanbankingnews.com - December 5 at 9:52 AM
Heska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departureHeska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departure
finance.yahoo.com - December 2 at 10:57 AM
Heska Corporation (HSKA) Receives Average Recommendation of "Hold" from BrokeragesHeska Corporation (HSKA) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - December 1 at 7:49 PM
Heska Corporation (HSKA) Insider Sells $681,957.64 in StockHeska Corporation (HSKA) Insider Sells $681,957.64 in Stock
www.americanbankingnews.com - November 29 at 7:54 PM
ETFs with exposure to Heska Corp. : November 27, 2017ETFs with exposure to Heska Corp. : November 27, 2017
finance.yahoo.com - November 27 at 5:29 PM
Heska Corp. – Value Analysis (NASDAQ:HSKA) : November 6, 2017Heska Corp. – Value Analysis (NASDAQ:HSKA) : November 6, 2017
finance.yahoo.com - November 8 at 8:27 PM
Heska Corporation (HSKA) Receives Average Recommendation of "Hold" from AnalystsHeska Corporation (HSKA) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 6 at 3:58 PM
Heska Corporation (HSKA) Price Target Cut to $93.00Heska Corporation (HSKA) Price Target Cut to $93.00
www.americanbankingnews.com - November 5 at 8:56 PM
Heska Corp (HSKA) Releases Quarterly  Earnings Results, Beats Expectations By $0.03 EPSHeska Corp (HSKA) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - November 4 at 2:06 PM
Heska Becomes Oversold (HSKA)Heska Becomes Oversold (HSKA)
www.thestreet.com - November 4 at 1:20 AM
Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : November 3, 2017Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : November 3, 2017
finance.yahoo.com - November 4 at 1:20 AM
Heskas (HSKA) CEO Kevin Wilson on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaHeska's (HSKA) CEO Kevin Wilson on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 3 at 7:24 AM
Heska Reports Third Quarter ResultsHeska Reports Third Quarter Results
finance.yahoo.com - November 3 at 7:24 AM
Heska beats 3Q profit forecastsHeska beats 3Q profit forecasts
finance.yahoo.com - November 3 at 7:24 AM
Edited Transcript of HSKA earnings conference call or presentation 2-Nov-17 3:00pm GMTEdited Transcript of HSKA earnings conference call or presentation 2-Nov-17 3:00pm GMT
finance.yahoo.com - November 3 at 7:24 AM
Heska Announces 7-Year Agreement with PetVetCare CentersHeska Announces 7-Year Agreement with PetVetCare Centers
finance.yahoo.com - November 2 at 1:06 AM
Heska extends product line with new Element COAG™ Veterinary AnalyzerHeska extends product line with new Element COAG™ Veterinary Analyzer
finance.yahoo.com - October 31 at 9:11 PM
ETFs with exposure to Heska Corp. : October 30, 2017ETFs with exposure to Heska Corp. : October 30, 2017
finance.yahoo.com - October 30 at 8:53 PM
 Analysts Expect Heska Corporation (HSKA) Will Post Quarterly Sales of $35.65 Million Analysts Expect Heska Corporation (HSKA) Will Post Quarterly Sales of $35.65 Million
www.americanbankingnews.com - October 27 at 10:58 AM
B. Riley Reiterates "Hold" Rating for Heska Corporation (HSKA)B. Riley Reiterates "Hold" Rating for Heska Corporation (HSKA)
www.americanbankingnews.com - October 27 at 7:58 AM
Heska Corporation (HSKA) to Release Earnings on ThursdayHeska Corporation (HSKA) to Release Earnings on Thursday
www.americanbankingnews.com - October 26 at 5:26 AM
 Analysts Expect Heska Corporation (HSKA) Will Announce Earnings of $0.39 Per Share Analysts Expect Heska Corporation (HSKA) Will Announce Earnings of $0.39 Per Share
www.americanbankingnews.com - October 25 at 8:36 AM
Heska Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017Heska Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017
finance.yahoo.com - October 13 at 12:12 AM
Heska Corporation (HSKA) Given Average Rating of "Hold" by AnalystsHeska Corporation (HSKA) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 12 at 5:04 PM
Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : October 9, 2017Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : October 9, 2017
finance.yahoo.com - October 9 at 7:40 PM
ETFs with exposure to Heska Corp. : October 9, 2017ETFs with exposure to Heska Corp. : October 9, 2017
finance.yahoo.com - October 9 at 7:40 PM
Heska Corp. :HSKA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017Heska Corp. :HSKA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 8:07 PM
Canaccord Genuity Begins Coverage on Heska Corporation (HSKA)Canaccord Genuity Begins Coverage on Heska Corporation (HSKA)
www.americanbankingnews.com - October 5 at 10:08 AM
HSKA Makes Notable Cross Below Critical Moving AverageHSKA Makes Notable Cross Below Critical Moving Average
www.thestreet.com - September 20 at 12:40 AM
TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP OpinionTESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion
finance.yahoo.com - September 18 at 7:08 PM
 Analysts Anticipate Heska Corporation (HSKA) Will Announce Earnings of $0.38 Per Share Analysts Anticipate Heska Corporation (HSKA) Will Announce Earnings of $0.38 Per Share
www.americanbankingnews.com - September 17 at 4:20 PM
$36.28 Million in Sales Expected for Heska Corporation (HSKA) This Quarter$36.28 Million in Sales Expected for Heska Corporation (HSKA) This Quarter
www.americanbankingnews.com - September 1 at 9:54 AM
Insider Selling: Heska Corporation (HSKA) EVP Sells 825 Shares of StockInsider Selling: Heska Corporation (HSKA) EVP Sells 825 Shares of Stock
www.americanbankingnews.com - August 31 at 7:44 PM
John Mcmahon Sells 2,608 Shares of Heska Corporation (HSKA) StockJohn Mcmahon Sells 2,608 Shares of Heska Corporation (HSKA) Stock
www.americanbankingnews.com - August 31 at 7:42 PM
Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : August 24, 2017Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : August 24, 2017
finance.yahoo.com - August 25 at 6:46 AM
Heska to Present at CL Kings 15th Annual Best Ideas Conference 2017 on September 14, 2017Heska to Present at CL King's 15th Annual Best Ideas Conference 2017 on September 14, 2017
finance.yahoo.com - August 24 at 7:38 AM
Heska Corporation (HSKA) Given Consensus Rating of "Hold" by AnalystsHeska Corporation (HSKA) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 23 at 5:18 PM
Heska Corp. – Value Analysis (NASDAQ:HSKA) : August 17, 2017Heska Corp. – Value Analysis (NASDAQ:HSKA) : August 17, 2017
finance.yahoo.com - August 17 at 12:36 AM
$0.42 EPS Expected for Heska Corporation (NASDAQ:HSKA) This Quarter$0.42 EPS Expected for Heska Corporation (NASDAQ:HSKA) This Quarter
www.americanbankingnews.com - August 11 at 9:04 PM
Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : August 4, 2017Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : August 4, 2017
finance.yahoo.com - August 4 at 7:52 PM
FY2017 Earnings Estimate for Heska Corporation Issued By Gabelli (HSKA)FY2017 Earnings Estimate for Heska Corporation Issued By Gabelli (HSKA)
www.americanbankingnews.com - August 4 at 11:08 AM
Heska Corporation (NASDAQ:HSKA) Price Target Raised to $129.50 at AegisHeska Corporation (NASDAQ:HSKA) Price Target Raised to $129.50 at Aegis
www.americanbankingnews.com - August 1 at 10:20 AM
Edited Transcript of HSKA earnings conference call or presentation 31-Jul-17 3:00pm GMTEdited Transcript of HSKA earnings conference call or presentation 31-Jul-17 3:00pm GMT
finance.yahoo.com - August 1 at 12:05 AM
Heskas (HSKA) CEO Kevin Wilson on Q2 2017 Results - Earnings Call TranscriptHeska's (HSKA) CEO Kevin Wilson on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 31 at 7:03 PM
Investor Network: HESKA CORP to Host Earnings CallInvestor Network: HESKA CORP to Host Earnings Call
finance.yahoo.com - July 31 at 7:03 PM
Heska Reports Second Quarter ResultsHeska Reports Second Quarter Results
finance.yahoo.com - July 31 at 7:03 PM
Heska posts 2Q profitHeska posts 2Q profit
finance.yahoo.com - July 31 at 7:03 PM
Heska Corporation (HSKA) Releases  Earnings Results, Beats Expectations By $0.07 EPSHeska Corporation (HSKA) Releases Earnings Results, Beats Expectations By $0.07 EPS
www.americanbankingnews.com - July 31 at 2:26 PM

SEC Filings

Heska (NASDAQ:HSKA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Heska (NASDAQ:HSKA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Heska (NASDAQ HSKA) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.